Caldwell Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Caldwell Trust's NVO Position: Q3 2026 in Review
Caldwell Trust held its Novo Nordisk (NVO) position steady in Q3 2026 at 50 shares worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #773.
Caldwell Trust first reported a position in NVO in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.69M in Q3 2024. 1,220 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Caldwell Trust held 50 shares of Novo Nordisk worth $1.9K as of Q3 2026.
- Caldwell Trust left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up ﹤0.01% of Caldwell Trust's portfolio in Q3 2026, its #773 holding.
- Caldwell Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 12 quarters since.
- Caldwell Trust's Novo Nordisk position peaked at $1.69M in Q3 2024.
- 1,220 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.